Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer

被引:5
|
作者
Valentin, B. [1 ]
Arsov, C. [2 ]
Ullrich, T. [1 ]
Demetrescu, D. [1 ]
Morawitz, J. [1 ]
Al-Monajjed, R. [2 ]
Quentin, M. [1 ]
Kirchner, J. [1 ]
Esposito, I [3 ]
Albers, P. [2 ]
Antoch, G. [1 ]
Schimmoeller, L. [1 ]
机构
[1] Univ Dusseldorf, Med Fac, Dept Diagnost & Intervent Radiol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Med Fac, Dept Urol, D-40225 Dusseldorf, Germany
[3] Univ Dusseldorf, Dept Pathol, Med Fac, D-40225 Dusseldorf, Germany
关键词
Prostatic neoplasms; Multiparametric magnetic resonance imaging; Diffusion magnetic resonance imaging; Magnetic resonance imaging; interventional; DIAGNOSTIC-ACCURACY; SCORING SYSTEM; MRI; VALIDATION; DISSECTION; BLADDER; RISK;
D O I
10.1016/j.ejrad.2021.110110
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: This study investigates preoperative lymph node metastases (LNM) detection accuracy by MRI and CT in patients with prostate cancer (PCA). Methods: All patients with preoperative MRI, CT or both and subsequent radical prostatectomy (RPE) and lymphadenectomy (LA) were included in this retrospective cohort study. Prostate specific antigen (PSA), PIRADS, ISUP grade group, clinical and pathological tumor (T) stage was compared between negative and positive nodal (N) stage. LNM were assessed with size and localization and weather they were preoperatively detected or not. In patients with preoperative CT and MRI, the results were compared intermodally. The reference standard was the histopathological results after RPE and LA. Results: A total of 228 patients were analysed including 24 patients with confirmed LNM (N1; 11%). PSA (median 9.7 vs. 14 ng/ml), PI-RADS (median 4 vs. 5), ISUP (median 2 vs. 4), and cT/pT-stage (median T2 vs. T3) was significantly higher in patients with LNM. No LNM were found in patients with ISUP-1-PCA. MRI was able to detect 67% of patients with LNM. Lymph node metastases presented on MRI predominantly small, round-shaped, located parailiacally with a minimum SAD of 4 mm (vs. CT SAD of 8 mm). In comparison, MRI was superior to CT in the detection of LNM (sensitivity 81% vs. 33%; specificity 99% vs. 97). Conclusion: LNM were very rare in patients with PSA < 10 ng/ml, PI-RADS < 4, and < cT2. MRI could detect LNM up to 4 mm with a moderate sensitivity and high specificity. Thus, MRI might optimise the preoperative diagnostic and therapy planning of patients with PCA, whereas CT was clearly limited for N-stage assessment.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Can sentinel pelvic lymph node dissection replace extended pelvic lymph node dissection in patients with prostate cancer?
    Günter Janetschek
    Nature Clinical Practice Urology, 2007, 4 : 636 - 637
  • [32] Can sentinel pelvic lymph node dissection replace extended pelvic lymph node dissection in patients with prostate cancer?
    Janetschek, Guenter
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (12): : 636 - 637
  • [33] The origin of lymph node metastases in prostate cancer
    Hong, Matthew
    Chung, Jessica
    Macintyre, Geoff
    Chin, Xiaowen
    Pedersen, John
    Costello, Anthony
    Hovens, Christopher
    Corcoran, Niall
    BJU INTERNATIONAL, 2013, 112 : 52 - 52
  • [34] The importance of SPECT-CT in sentinel lymph node detection with prostate cancer patients
    Balogh, Ildiko
    Paczelt, Andras
    Varga, Jozsef
    Pocza, Karoly
    Galler, Zoltan
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [35] Cost-effectiveness of MR Lymphography for the Detection of Lymph Node Metastases in Patients with Prostate Cancer
    Hovels, Anke M.
    Heesakkers, Roel A. M.
    Adang, Eddy M. M.
    Barentsz, Jelle O.
    Jager, Gerrit J.
    Severens, Johan L.
    RADIOLOGY, 2009, 252 (03) : 729 - 736
  • [36] Comparison between 68Ga-PSMA PET/CT and mpMRI to detect local recurrence of prostate cancer and local lymph node restaging in patients with biochemical recurrence of prostate cancer
    Zemniece, L.
    Roznere, L.
    Tirane, M.
    Kalnina, M.
    Lietuvietis, V.
    Freimanis, A.
    Vjaters, E.
    Radzina, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S528 - S529
  • [37] Comparison of Different Tools to Predict the Risk of Lymph Node Invasion (LNI) in Prostate Cancer Patients Undergoing Sentinel Lymph Node (SLN) Detection and Extended Pelvic Lymph Node Dissection (ePLND)
    Rousseau, C.
    Campion, L.
    Rousseau, T.
    Lacoste, J.
    Allier, G.
    Potiron, E.
    Le Goguic, G.
    Kraeber-Bodere, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S355 - S355
  • [38] 18F-choline PET/CT for the assesment of pelvic lymph node metastases in high-risk prostate cancer patients.
    Federico Pinto, Ivan
    Sandoval, Camilo
    Gonzalo Diaz, Jorge
    Daniel Vidal, Alvaro
    Antonio Altamirano, Jaime
    Mauricio Vilches, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [39] HYPOGONADISM IS AN INDEPENDENT PREDICTOR OF NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION
    Ventimiglia, Eugenio
    Capogrosso, Paolo
    Colicchia, Michele
    Boeri, Luca
    Serino, Alessandro
    Castagna, Giulia
    Castiglione, Fabio
    La Croce, Giovanni
    Rocchini, Lorenzo
    Gallina, Andrea
    Suardi, Nazareno
    Briganti, Alberto
    Damiano, Rocco
    Montorsi, Francesco
    Salonia, Andrea
    JOURNAL OF UROLOGY, 2014, 191 (04): : E420 - E420